COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity - He, Na; Li, Guosheng; Liu, Jinting; Liu, Wancheng; Tian, Ruifeng; Ma, Daoxin (Frontiers in Immunology, 2024)